WCN26-8669 SEROPOSITIVITY AGAINST SARS-CoV-2 AND COVID-19 INFECTION IN HEMODIALYSIS PATIENTS VACCINATED AGAINST THE DISEASE

Read full text Summarise with VIRAT
Authors: Edwin Pérez Tejada, Jessica I. Bravo-Zuñiga, Anselma Pardo, Carlos Enrique Tapia Zerpa, María Teresa Lopera Quintanilla, EDUARDO LUNA VICTORIA DIAZ, Percy Soto-Becerra, PERCY HERRERA AÑAZGO
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This study evaluated the effectiveness of the anti–COVID-19 vaccine in a long-term chronic hemodialysis population by measuring vaccine-induced antibody levels, and assessing the incidence of infection, hospitalization, intensive care admission, or death due to SARS-CoV-2 infection at 6 and 9 months following vaccination.

Fields of Study & Subjects

SARS-CoV-2 and COVID-19 Research COVID-19 Clinical Research Studies Vaccine Coverage and Hesitancy

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105342–105342
Publication date
25 March 2026
Language
EN